GLPwatch
Papers (9189)
Page 131 of 154, ranked by citation count.
- Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
- 68Ga-NODAGA-Exendin-4 PET/CT Findings in a Case of Metastatic Insulinoma With Refractory Hypoglycemia Controlled by 90Y Transarterial Radioembolization.
- Glycemia reduction in type 2 diabetes-Hypoglycemia outcomes: A randomized clinical trial.
- Effects of glucagon-like peptide 1 receptor signaling in the dorsolateral septum on ethanol operant self-administration and relapse behaviors.
- Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study.
- Is tirzepatide 15 mg the preferred treatment strategy for type 2 diabetes? A meta-analysis and trial-sequence-analysis.
- [For obese patients or for patients who are overweight and have an associated comorbidity, how safe and effective is semaglutide as compared with placebo as an adjunct to lifestyle intervention for reducing body weight and other related end points?]
- People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment.
- Sixty seconds on . . . semaglutide.
- Engineering Marker-Free Lettuce Chloroplast Genome to Express Functional Glucagon-Like Peptide-1 Receptor Agonists Exenatide and Lixisenatide.
- The Antidiabetic Armamentarium: Reducing the Residual Cardiovascular Risk with HbA<sub>1c(v)</sub>-Lowering Medications : Editorial to: "GLP-1 Receptor Agonists and Cardiovascular Disease: A Meta-Analysis of Recent Cardiac Outcome Trials" by Jia X, Alam M, Ye Y et al.
- Glucagon-like peptide-1 receptor agonists for the treatment of opioid use disorders: a systematic review.
- Distinguishing among incretin-based therapies. Introduction.
- The LEADER trial in type 2 diabetes: Were the characteristics and outcomes of the participants representative?
- Sex Differences in Effectiveness of Semaglutide in Patients With Peripheral Artery Disease: The STRIDE Trial.
- [New blood glucose-lowering drugs in type 2 diabetes: a review of the literature].
- Cost-effectiveness of Semaglutide Compared With Other Glucose-Lowering Medications in Treating Type 2 Diabetes: A Comprehensive Systematic Review and Meta-analysis.
- Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
- Semaglutide and Cardiovascular Outcomes. Reply.
- Automated production of [<sup>68</sup>Ga]Ga-DOTA-exendin-4 via fractionated radionuclide generator elution on a cassette based synthesis module.
- Semaglutide: A New Medical Swiss Army Knife?
- High BMI z-Scores from Different Growth References Are Not Comparable: An Example from a Weight Management Trial with an Anti-Obesity Medication in Pubertal Adolescents with Obesity.
- Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity.
- Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity.
- Impact of GLP-1 and dual agonists on the incidence of new cases of physician-reported sleep apnea: a real-world study.
- Meta-analysis of the effects of semaglutide on body mass index (BMI) and blood lipid levels in polycystic ovary syndrome patients.
- Incretin Analogs for Weight Management in Adults Without Diabetes.
- [Treatment of non-alcoholic fatty liver disease].
- The adverse effects associated with semaglutide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.
- The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice.
- Proteomic pathways across the ejection fraction spectrum in patients with heart failure and diabetes mellitus: an EXSCEL trial substudy.
- Efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg for the management of overweight or obesity in Asian populations: A systematic review, meta-analysis and meta-regression of randomised trials.
- US eligibility and preventable cardiovascular disease events from semaglutide in type 2 diabetes.
- [The effects of compound CX09040 on the inhibition of PTP1B and protection of pancreatic β cells].
- A review regarding the article 'Semaglutide and heart failure: Updated meta-analysis'.
- Influence of Combination Therapy with Dulaglutide or Liraglutide and SGLT2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Post-hoc Analysis of the RECAP Study.
- Time-Matched Evaluation of Cardiovascular Risks Associated with Drugs for Type 2 Diabetes Mellitus.
- Med14 phosphorylation shapes genomic response to GLP-1 agonists.
- Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3.
- More on Semaglutide in Early Type 1 Diabetes.
- Glucagon-Like Peptide 1 Receptor Agonists and Cardiovascular Disease.
- Hypothalamic RASA1/Ras/AKT/GnRH axis reprogramming mediates GLP-1RA's central rescue of PCOS HPG dysfunction.
- New therapeutic options: management strategies to optimize glycemic control.
- Semaglutide Associated With Less Insulin Need in Early Type 1 Diabetes.
- Liraglutide ameliorates intrauterine adhesion by inhibiting NF-κb phosphorylation and reducing epithelial-mesenchymal transition.
- Management of diabetes and pancreatic cancer.
- Impact of Incretin-Based Therapy on Skeletal Muscle Health.
- Effects of dipeptidyl peptidase-4 inhibitors in a type 2 diabetes patient with failure of glucagon-like peptide-1 receptor agonists.
- Exendin-4 Prevents oxLDL-Induced upregulation of TREM2 and attenuates foam cell formation and inflammation in Macrophages.
- Acute Duodenal Ulcer Perforation Following Tirzepatide Treatment: A Case Report.
- Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population-Based Propensity-Score-Adjusted Analysis.
- Characterizing the D-Amino Acid Position in Peptide Epimers by Using Higher-Energy Collisional Dissociation Tandem Mass Spectrometry: A Case Study of Liraglutide.
- The effects of the GLP1 analog liraglutide on allodynia and motor coordination in peripheral neuropathy induced by a chemotherapeutic agent, cisplatin.
- Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J-mono and J-combo studies.
- Is global interest in fasting, intermittent fasting and the liver shifting?
- A Hypercaloric Diet Induces Early Podocyte Damage in Aged, Non-Diabetic Rats.
- A biodegradable suction patch for sustainable transbuccal peptide delivery.
- Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management.
- Liraglutide modulates adhesion molecules and enhances cell properties in three-dimensional cultures of olfactory ensheathing cells.
- Exogenous oral application of PYY and exendin-4 impacts upon taste-related behavior and taste perception in wild-type mice.